200 related articles for article (PubMed ID: 19608680)
1. Imbalanced globin chain synthesis determines erythroid cell pathology in thalassemic mice.
Srinoun K; Svasti S; Chumworathayee W; Vadolas J; Vattanaviboon P; Fucharoen S; Winichagoon P
Haematologica; 2009 Sep; 94(9):1211-9. PubMed ID: 19608680
[TBL] [Abstract][Full Text] [Related]
2. Differential regulatory and compensatory responses in hematopoiesis/erythropoiesis in alpha- and beta-globin hemizygous mice.
Beauchemin H; Blouin MJ; Trudel M
J Biol Chem; 2004 May; 279(19):19471-80. PubMed ID: 15004025
[TBL] [Abstract][Full Text] [Related]
3. Abnormal assembly of membrane proteins in erythroid progenitors of patients with beta-thalassemia major.
Aljurf M; Ma L; Angelucci E; Lucarelli G; Snyder LM; Kiefer CR; Yuan J; Schrier SL
Blood; 1996 Mar; 87(5):2049-56. PubMed ID: 8634456
[TBL] [Abstract][Full Text] [Related]
4. Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle.
Bohl D; Bosch A; Cardona A; Salvetti A; Heard JM
Blood; 2000 May; 95(9):2793-8. PubMed ID: 10779423
[TBL] [Abstract][Full Text] [Related]
5. siRNA-mediated reduction of alpha-globin results in phenotypic improvements in beta-thalassemic cells.
Voon HP; Wardan H; Vadolas J
Haematologica; 2008 Aug; 93(8):1238-42. PubMed ID: 18556409
[TBL] [Abstract][Full Text] [Related]
6. betaMinor-globin messenger RNA accumulation in reticulocytes governs improved erythropoiesis in beta thalassemic mice after erythropoietin complementary DNA electrotransfer in muscles.
Samakoglu S; Fattori E; Lamartina S; Toniatti C; Stockholm D; Heard JM; Bohl D
Blood; 2001 Apr; 97(8):2213-20. PubMed ID: 11290581
[TBL] [Abstract][Full Text] [Related]
7. Isolation and in vitro differentiation of human erythroid precursor cells.
Kim HC; Marks PA; Rifking RA; Maniatis GM; Bank A
Blood; 1976 May; 47(5):767-76. PubMed ID: 1260133
[TBL] [Abstract][Full Text] [Related]
8. Correction of β654-thalassaemia mice using direct intravenous injection of siRNA and antisense RNA vectors.
Xie SY; Li W; Ren ZR; Huang SZ; Zeng F; Zeng YT
Int J Hematol; 2011 Mar; 93(3):301-310. PubMed ID: 21369857
[TBL] [Abstract][Full Text] [Related]
9. Molecular Basis and Genetic Modifiers of Thalassemia.
Mettananda S; Higgs DR
Hematol Oncol Clin North Am; 2018 Apr; 32(2):177-191. PubMed ID: 29458725
[TBL] [Abstract][Full Text] [Related]
10. alpha-Thalassemia-like globin gene expression by primitive erythrocytes derived from human embryonic stem cells.
Honig GR; Lu SJ; Feng Q; Vida LN; Lee BS; Lanza R
Hemoglobin; 2010 Jan; 34(2):145-50. PubMed ID: 20353349
[TBL] [Abstract][Full Text] [Related]
11. Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells.
Pavani G; Fabiano A; Laurent M; Amor F; Cantelli E; Chalumeau A; Maule G; Tachtsidi A; Concordet JP; Cereseto A; Mavilio F; Ferrari G; Miccio A; Amendola M
Blood Adv; 2021 Mar; 5(5):1137-1153. PubMed ID: 33635334
[TBL] [Abstract][Full Text] [Related]
12. The thalassemic red cell membrane.
Wilairat P; Kittikalayawong A; Chaicharoen S
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():74-8. PubMed ID: 1298998
[TBL] [Abstract][Full Text] [Related]
13. Imbalanced globin chain synthesis in heterozygous beta-thalassemic bone marrow.
Chalevelakis G; Clegg JB; Weatherall DJ
Proc Natl Acad Sci U S A; 1975 Oct; 72(10):3853-7. PubMed ID: 1060068
[TBL] [Abstract][Full Text] [Related]
14. Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia.
Suragani RN; Cawley SM; Li R; Wallner S; Alexander MJ; Mulivor AW; Gardenghi S; Rivella S; Grinberg AV; Pearsall RS; Kumar R
Blood; 2014 Jun; 123(25):3864-72. PubMed ID: 24795345
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of beta thalassemia--a guide to molecular therapies.
Thein SL
Hematology Am Soc Hematol Educ Program; 2005; ():31-7. PubMed ID: 16304356
[TBL] [Abstract][Full Text] [Related]
16. Relationship between AHSP gene expression, β/α globin mRNA ratio, and clinical severity of the β-thalassemia patients.
Ranjbaran R; Okhovat MA; Mobarhanfard A; Aboualizadeh F; Abbasi M; Moezzi L; Golafshan HA; Behzad-Behbahani A; Bagheri M; Sharifzadeh S
Ann Clin Lab Sci; 2014; 44(2):189-93. PubMed ID: 24795058
[TBL] [Abstract][Full Text] [Related]
17. Globin synthesis in fractionated Normoblasts of beta-thalassemia heterozygotes.
Wood WG; Stamatoyannopoulos G
J Clin Invest; 1975 Mar; 55(3):567-78. PubMed ID: 1167870
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress and β-thalassemic erythroid cells behind the molecular defect.
De Franceschi L; Bertoldi M; Matte A; Santos Franco S; Pantaleo A; Ferru E; Turrini F
Oxid Med Cell Longev; 2013; 2013():985210. PubMed ID: 24205432
[TBL] [Abstract][Full Text] [Related]
19. Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy.
Persons DA; Allay ER; Sabatino DE; Kelly P; Bodine DM; Nienhuis AW
Blood; 2001 May; 97(10):3275-82. PubMed ID: 11342459
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of FV vectors with human α- or β-globin gene regulatory elements for the correction of β-thalassemia.
Morianos I; Siapati EK; Pongas G; Vassilopoulos G
Gene Ther; 2012 Mar; 19(3):303-11. PubMed ID: 21734726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
